Pharmaceuticals This is an OPML file. It can be used to export all the MedWorm RSS feeds on this topic into your personal RSS reader (usually you have to save this file to your own computer before clicking on an Import OPML command in your own feed reader to upload the file which will then import all the feeds) or it can be used by webmasters to integrate MedWorm feeds with their own website. This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader, such as GoogleReader, or to display this data on your own website or blog. Subscribe to this data using MyMedWorm.Subscribe to this data using GoogleReader.Subscribe to this data using Bloglines.Subscribe to this data using MyYahoo.

This page shows you the most recent publications within this specialty of the MedWorm directory. This is page number 9.

Dune Medical Devices Announces European Union Approval of the MarginProbe(R) System Type 1.2
CE Approval Allows Marketing of Portable, Compact MarginProbe System BOSTON, Feb. 19, 2013 -- (Healthcare Sales & Marketing Network) -- Dune Medical Devices announced today that it has received CE approval for compliance with the European Union's medic... Devices, Oncology, RegulatoryDune Medical Devices, MarginProbe, breast cancer
Source: HSMN NewsFeed - February 19, 2013 Category: Pharmaceuticals Source Type: news

The 7 Habits of Highly Patient Centric Providers
Since Dr. Farzad Mostashari's (the U.S. "healthIT czar") keynote presentation at the 2012 HIMSS conference, I've repeatedly heard that 2013 is the year of patient engagement. Dr. Mostashari unveiled the latest requirements to tap stimulus dollars and virtually all of the new items were around patient engagement. As Lygeia Ricciardi of the ONC recently stated, the ONC is going all-in on patient engagement. Why the focus
Source: Forbes.com Healthcare News - February 19, 2013 Category: Pharmaceuticals Authors: Dave Chase Source Type: news

Independent Study Demonstrates Clinical Advantages Of Kiva(R) Over Balloon Kyphoplasty
Spine Publishes Results Showing Kiva Restored Deformity and Reduced Extravasation SANTA CLARA, Calif., Feb. 19, 2013 -- (Healthcare Sales & Marketing Network) -- An independent, prospective, randomized study of patients with vertebral compression fract... Devices, Neurosurgery, OrthopaedicBenvenue Medical, vertebral compression fracture, balloon kyphoplasty, Kiva VCF
Source: HSMN NewsFeed - February 19, 2013 Category: Pharmaceuticals Source Type: news

Regeneron and Bayer Initiate Phase 3 Trial of Eylea (aflibercept) Injection for the Treatment of Diabetic Macular Edema in Asia and Russia
TARRYTOWN, N.Y. and BERLIN, Feb. 19, 2013 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Bayer HealthCare today announced that they have initiated a new Phase 3 trial (named VIVID EAST-DME) to evaluate the efficacy and safety of...
Source: Drugs.com - Pharma News - February 19, 2013 Category: Pharmaceuticals Source Type: news

Isis Initates Phase 2/3 Study Of ISIS-TTR Rx And Earns $7.5 Million Milestone Payment From GlaxoSmithKline
CARLSBAD, Calif., Feb. 19, 2013 /PRNewswire/ -- Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) announced today that it has earned a $7.5 million milestone payment from GlaxoSmithKline (GSK) related to the initiation of a Phase 2/3 clinical study...
Source: Drugs.com - Pharma News - February 19, 2013 Category: Pharmaceuticals Source Type: news

Novartis Board of Directors and Dr. Daniel Vasella agree to cancel the non-compete agreement and all related compensation; Decision taken to address concerns of stakeholders
Basel, 19 February 2013 - Novartis announced that the Novartis Board of Directors and Dr. Daniel Vasella have agreed to cancel his non-compete agreement with Novartis and all related conditional compensation. The agreement was to take effect after...
Source: Drugs.com - Pharma News - February 19, 2013 Category: Pharmaceuticals Source Type: news

Sanofi India to double consumer healthcare biz to Rs 1,000 cr
Sanofi India (previously known as Aventis Pharma) today said it aims to double its consumer healthcare business in the next five years.
Source: The Economic Times Healthcare and Biotech News - February 19, 2013 Category: Pharmaceuticals Source Type: news

GSK and Theravance announce FDA acceptance of New Drug Application (NDA) submission in the US for ANORO ELLIPTATM for COPD
Source: GSK news - February 19, 2013 Category: Pharmaceuticals Source Type: news

Omega Healthcare plans to strengthen operations offshore
Healthcare service provider Omega Healthcare has planned to strengthen operations in the offshore healthcare market with the inauguration of its fourth facility in the country and third in Tamil Nadu today.
Source: The Economic Times Healthcare and Biotech News - February 19, 2013 Category: Pharmaceuticals Source Type: news

Why Spend $900 Billion On Health Insurance?
Although Obamacare is intensely focused on getting insurance access to all, one must ask: Is healthcare insurance part of the problem or part of the solution?
Source: Forbes.com Healthcare News - February 19, 2013 Category: Pharmaceuticals Authors: Michael Bell Source Type: news

Six Healthy Carbs To Help You Lose Weight
English: Dagwinkel foodstores fresh fruits & vegetables (Photo credit: Wikipedia)
Source: Forbes.com Healthcare News - February 19, 2013 Category: Pharmaceuticals Authors: Robert Glatter, MD Source Type: news

Novartis scraps chairman’s $78m payout
Mounting anger from shareholders forces the Swiss pharmaceutical group into a U-turn over a controversial ‘golden gag’ for Daniel Vasella
Source: FT.com - Drugs and Healthcare - February 19, 2013 Category: Pharmaceuticals Source Type: news

Extractables and Leachables for Medical Devices: Meeting the 510(k) Requirements
Recent changes in the FDA's 510(k) requirements for medical device applications have spawned many inquiries from clients on how to address the request for extractables, leachables and drug compatibility data.
Source: Pharmaceutical Technology - February 19, 2013 Category: Pharmaceuticals Source Type: news

Analytical Challenges Presented by Leachables from Sample Container Closure Systems in Drug Products
Leachables are compounds that migrate into a drug product from the sample container closure system (SCC) under nromal storage conditions.
Source: Pharmaceutical Technology - February 19, 2013 Category: Pharmaceuticals Source Type: news

FDA is Increasing Regulations on Excipients Worldwide – What Can Your Company Do to Reduce Risk?
Since 2008, when patient deaths were first linked to tainted raw materials used in the manufacture of heparin, the US Food and Drug Administration (FDA) and other regulatory agencies have been taking a much closer look at drug manufacturing supply ch…
Source: Pharmaceutical Technology - February 19, 2013 Category: Pharmaceuticals Source Type: news

What Will Eventually Wake Up the US Pharma Industry to the Importance of Quality; the Stick, or the Carrot?
Roll the clock back to the early 2000s - groundbreaking discussions between FDA and Industry that led to the 'cGMP for the 21st Century' philosophy - science and risk-based approaches to quality.
Source: Pharmaceutical Technology - February 19, 2013 Category: Pharmaceuticals Source Type: news

Proposed New European Regulation for Medical Devices to Replace 93/42/EEC and 90/385/EEC
The Commission proposal for a new regulation to cover medical devices and active implantable medical devices was published on 26 September 2012.
Source: Pharmaceutical Technology - February 19, 2013 Category: Pharmaceuticals Source Type: news

New Zealand to Propose Plain Cigarette Packs
Following Australia's lead, New Zealand's government said it will introduce "plain-packaging" legislation for tobacco products by the end of the year.
Source: WSJ.com: Health - February 19, 2013 Category: Pharmaceuticals Tags: PAID Source Type: news

'Big Pharma' Fails At Self-Policing ED Drug Advertising: Study
The pharmaceutical industry's efforts to self-regulate its direct-to-consumer (DTC) advertising are "an industry-sponsored ruse," intended to deflect criticism and collectively block new Federal regulation, a study released in the Journal of Health Politics, Policy and Law found...
Source: Health News from Medical News Today - February 19, 2013 Category: Consumer Health News Tags: Pharma Industry / Biotech Industry Source Type: news

A New Way Of Looking At Drug Discovery
Garret FitzGerald, MD, FRS, chair of the Department of Pharmacology and Director of the Institute for Translational Medicine & Therapeutics, Perelman School of Medicine at the University of Pennsylvania, has long said the current drug-development system in the United States is in need of change, "representing an unsustainable model...
Source: Health News from Medical News Today - February 19, 2013 Category: Consumer Health News Tags: Pharma Industry / Biotech Industry Source Type: news

Single Molecule Sieves Developed To Separate Complex Molecular Mixtures
Chemists at the University of Liverpool have created a new technique that could be used in industry to separate complex organic chemical mixtures. Chemical feedstocks containing benzene are used extensively in industry to create modern materials and polymers. Their use relies heavily on distillation techniques which separate complex mixtures into more simple molecules used as building blocks to develop drugs, plastics and new materials. These distillation techniques can be expensive and involve large amounts of energy for hard-to-separate mixtures...
Source: Health News from Medical News Today - February 19, 2013 Category: Consumer Health News Tags: Pharma Industry / Biotech Industry Source Type: news

Nano-Machines For 'Bionic Proteins'
Physicists of the University of Vienna together with researchers from the University of Natural Resources and Life Sciences Vienna developed nano-machines which recreate principal activities of proteins. They present the first versatile and modular example of a fully artificial protein-mimetic model system, thanks to the Vienna Scientific Cluster (VSC), a high performance computing infrastructure. These "bionic proteins" could play an important role in innovating pharmaceutical research. The results have now been published in the renowned journal Physical Review Letters...
Source: Health News from Medical News Today - February 19, 2013 Category: Consumer Health News Tags: Pharma Industry / Biotech Industry Source Type: news

For Drug Makers, New 3-D Control Opens Wealth Of Option
A team of scientists anchored at Yale University has demonstrated a new, highly versatile approach for quickly assembling drug-like compounds, establishing a broad new route to drug discovery and medical treatment.
Source: Pharmaceutical Online News - February 19, 2013 Category: Pharmaceuticals Source Type: news

ONDANSETRON (Ondansetron Hydrochloride) Solution [Aurobindo Pharma Limited]
Updated Date: Feb 19, 2013 EST
Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST) - February 19, 2013 Category: Drugs & Pharmacology Source Type: news

IBUPROFENtablet, Film Coated [Med Health Pharma, LLC]
Updated Date: Feb 19, 2013 EST
Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST) - February 19, 2013 Category: Drugs & Pharmacology Source Type: news

Hard-Wired to Hate Exercise?
Discipline and motivation aside, researchers are looking at the physiological reasons behind why some people enjoy exerting themselves and others don't.
Source: WSJ.com: Health - February 18, 2013 Category: Pharmaceuticals Tags: FREE Source Type: news

'I Don't Smoke, Doc,' and Other Patient Lies
From half truths to bold, blatant lies, why patients fib when talking to their doctor.
Source: WSJ.com: Health - February 18, 2013 Category: Pharmaceuticals Tags: FREE Source Type: news

Pay Plan Could Limit Children's Dental Coverage
The 2010 health law provides dental coverage for lower-income children. But some people in the dental business say the number signing up for new plans may be lower than hoped, because people are likely to have to pay for the benefit separately.
Source: WSJ.com: Health - February 18, 2013 Category: Pharmaceuticals Tags: PAID Source Type: news

Naturopathic shenanigans in the Maryland legislature
Quacks never give up. In their never-ending quest to make money from bogus treatments, they try all kinds of strategies to convince people that what they're selling really, really works, despite the evidence to the contrary.
Source: Forbes.com Healthcare News - February 18, 2013 Category: Pharmaceuticals Authors: Steven Salzberg Source Type: news

Eriez E-Z Tec XR-Bulk X-Ray Inspection Systems Provide Protection For Bulk Flow Applications
Eriez(r) introduces its new E-Z Tec(r) XR-Bulk X-Ray Inspection System.
Source: Pharmaceutical Online News - February 18, 2013 Category: Pharmaceuticals Source Type: news

Pay Plan Could Limit Children's Dental Coverage Under Law
The 2010 health law provides dental coverage for lower-income children, some of whom don't get their teeth checked regularly. But some people in the dental business say the number signing up for new plans may be lower than hoped, because people are likely to have to pay for the benefit separately.
Source: WSJ.com: Health - February 18, 2013 Category: Pharmaceuticals Tags: PAID Source Type: news

Australian government to provide $220m subsidy for important medicines
The Australian government is to provide $220m to subsidise vital medicines such as boceprevir and telaprevir, both prescribed for chronic hepatitis C, in a bid to help save more lives.
Source: Pharmaceutical Technology - February 18, 2013 Category: Pharmaceuticals Source Type: news

Novartis to scrap controversial payout to chairman Daniel Vasella
Swiss drug maker Novartis will cancel a CHF72m ($78m) package intended to prevent chairman Dr Daniel Vasella from sharing his expert knowledge when he resigns on Friday.
Source: Pharmaceutical Technology - February 18, 2013 Category: Pharmaceuticals Source Type: news

Cremer-Tablet and Capsule Counting Machines
The Cremer CF counting machine is a high-speed tablet and capsule counting machine for pharmaceutical and para-pharma industries - medicines, vitamins, food supplements, health products etc. In 1982 ...
Source: Pharmaceutical Technology - February 18, 2013 Category: Pharmaceuticals Source Type: news

Therapure Biopharma-Development, Scale Up and Manufacture of Complex Biologics
Therapure Biopharma is a contract development and manufacturing organization (CDMO) that specializes in the development, scale up and manufacture of complex biologics.
Source: Pharmaceutical Technology - February 18, 2013 Category: Pharmaceuticals Source Type: news

Atlab reports positive data from Phase II study of ATL101
France-based Atlab Pharma has reported positive data from a Phase II study of ATL101 (Lutetium-177 anti-PSMA antibody), conducted in patients with progressive metastatic castrate-resistant prostate cancer (mCRPC
Source: Drug Development Technology - February 18, 2013 Category: Pharmaceuticals Source Type: news

Roche, Chiasma partner to develop, commercialise Octreolin
Roche and Chiasma have partnered to develop and commercialise Octreolin, an investigational oral regimen for acromegaly and neuroendocrine tumours.
Source: Drug Development Technology - February 18, 2013 Category: Pharmaceuticals Source Type: news

Push for New Ways to Research Rare Diseases
Families of children with rare diseases want scientists to share patient data, a move public-health officials say could encourage more efforts to develop medicines for the illnesses.
Source: WSJ.com: Health - February 18, 2013 Category: Pharmaceuticals Tags: FREE Source Type: news

Phytopharm’s Parkinson’s drug flops
Biotech company’s drug, Cogane, showed no effect in a mid-stage clinical trial in more than 400 patients, sending shares down more than 80 per cent
Source: FT.com - Drugs and Healthcare - February 18, 2013 Category: Pharmaceuticals Source Type: news

SHARE REPURCHASE 18.2.2013
QPR Software Plc ANNOUNCEMENT 18.2.2013 SHARE REPURCHASE 18.2.2013 In the Helsinki Stock Exchange Trade date 18.2.2013 Bourse trade Buy Share
Source: Medical News (via PRIMEZONE) - February 18, 2013 Category: Pharmaceuticals Source Type: news

Closing Values Confirmed for Nordic and International market
Source: Medical News (via PRIMEZONE) - February 18, 2013 Category: Pharmaceuticals Source Type: news

DGAP-PVR: Fresenius Medical Care AG & Co. KGaA: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
Fresenius Medical Care AG & Co. KGaA 18.02.2013 17:35 Dissemination of a Voting Rights Announcement, transmitted by DGAP - a company of EquityStory AG. The issuer is solely responsible for the content of this announcement. --------------------------------------------------------------------------- Correction of the release of February 15, 2013 according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution On February 13, 2
Source: Medical News (via PRIMEZONE) - February 18, 2013 Category: Pharmaceuticals Source Type: news

Rapala VMC Corporation: SHARE REPURCHASE 18.2.2013
Rapala VMC Corporation STOCK EXCHANGE ANNOUNCEMENT 18.2.2013 SHARE REPURCHASE 18.2.2013 In the Helsinki Stock Exchange Trade date 18.2.2013 Bourse trade BUY Share RAP1V Amount 2.625 shares Total cost 12.678,75 EUR Average price/ share 4,8300 EUR Highest price/ share 4,83 EUR Lowest price/ share 4,83 EUR Rapala VMC Corporation now holds a total of 706.025 shares including the shares repurchased on 18.2
Source: Medical News (via PRIMEZONE) - February 18, 2013 Category: Pharmaceuticals Source Type: news

Rapala VMC Oyj: OMIEN OSAKKEIDEN HANKINTA 18.2.2013
Rapala VMC Oyj PÖRSSI-ILMOITUS 18.2.2013 OMIEN OSAKKEIDEN HANKINTA 18.2.2013 Helsingin Pörssi Päivämäärä 18.2.2013 Pörssikauppa Osto Osakelaji RAP1V Osakemäärä 2 625 osaketta Kokonaishinta 12 678,75 EUR Keskihinta/ osake 4,8300 EUR Ylin hankintahinta/ osake 4,83 EUR Alin hankintahinta/ osake 4,83 EUR Yhtiön hallussa olevat omat osakkeet 18.2.2013 tehtyjen kauppojen
Source: Medical News (via PRIMEZONE) - February 18, 2013 Category: Pharmaceuticals Source Type: news

FASTSIGNS(R) Heads to CFA's The Franchise Show to Educate Potential Partners
CARROLLTON, Texas, Feb. 18, 2013 (GLOBE NEWSWIRE) --
Source: Medical News (via PRIMEZONE) - February 18, 2013 Category: Pharmaceuticals Source Type: news

Selskabsmeddelelse 02/2013 om årsrapport 2012
Jævnfør vedhæftning.
Source: Medical News (via PRIMEZONE) - February 18, 2013 Category: Pharmaceuticals Source Type: news

Årsrapport 2012
Jævnfør vedhæftning.
Source: Medical News (via PRIMEZONE) - February 18, 2013 Category: Pharmaceuticals Source Type: news

Selskabsmeddelelse 02/2013 om årsrapport 2012
Jævnfør vedhæftning.
Source: Medical News (via PRIMEZONE) - February 18, 2013 Category: Pharmaceuticals Source Type: news

Årsrapport 2012
Jævnfør vedhæftning.
Source: Medical News (via PRIMEZONE) - February 18, 2013 Category: Pharmaceuticals Source Type: news

Nytt datum för årsstämma
Duroc ändrar datum för årsstämma till 6 maj 2013 istället för som tidigare kommunicerats 7 maj 2013. Stämman kommer att hållas i bolagets lokaler, Berga Backe 4, i Danderyd kl 16.00. För ytterligare information Erik Albinsson, koncernchef Duroc, 070-492 78 33 Informationen är sådan som Duroc AB (publ) är skyldigt att offentliggöra enligt lagen om värdepappersmarknaden och lagen om handel med finansiella instrument. Informationen lämnades för offentliggörande den 18 februari 2013 kl 17.55.
Source: Medical News (via PRIMEZONE) - February 18, 2013 Category: Pharmaceuticals Source Type: news